Page last updated: 2024-08-23

razoxane and Leukemia, Myeloid, Acute

razoxane has been researched along with Leukemia, Myeloid, Acute in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-199011 (55.00)18.7374
1990's4 (20.00)18.2507
2000's1 (5.00)29.6817
2010's4 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gallegos-Castorena, S; Gonzalez-Ramella, O; Sánchez-Medina, J1
Anderson, P; Chandra, J; Fulbright, JM; Huh, W1
Asselin, BL; Athale, UH; Clavell, L; Cohen, HJ; Cole, PD; Kelly, KM; Larsen, EC; Laverdière, C; Lipshultz, SE; Michon, B; Neuberg, DS; Sallan, SE; Schorin, M; Schwartz, CL; Silverman, LB; Stevenson, KE; Vrooman, LM1
Aplenc, R; Fisher, BT; Huang, YS; Li, Y; Seif, AE; Torp, K; Walker, DM1
Lipshultz, SE; Lipsitz, SR; Orav, EJ1
Barrett, AJ; Joshi, R; Phillips, RH; Smith, B1
Creighton, AM1
Griffiths, WA; Levene, GM; Steinman, HK1
Davidson, RN; Hiwaizi, F; Lakhani, S; Marsden, RA1
Caffrey, EA; Clark, KG; Daker, MG; Horton, JJ; MacDonald, DM; Wells, RS1
Gao, LS; Wang, XY; Zhang, MH1
Lemez, P; Maresová, J1
DiSalle, M; Lifton, R; Woodlock, TJ1
Bhavnani, M; Delamore, IW; Dhir, K1
Shaw, D; Tudhope, GR1
Guo, Y; Lin, B; Lu, D; Xue, Y1
Bhavnani, M; Wolstenholme, RJ1
Caffrey, EA; Daker, MG; Horton, JJ1
Griffiths, WA1

Reviews

1 review(s) available for razoxane and Leukemia, Myeloid, Acute

ArticleYear
Can anthracycline therapy for pediatric malignancies be less cardiotoxic?
    Current oncology reports, 2010, Volume: 12, Issue:6

    Topics: Adolescent; Adult; Anthracyclines; Child; Delayed-Action Preparations; Disease Progression; Doxorubicin; Drug Administration Schedule; Drug Carriers; Drug Dosage Calculations; Drug-Related Side Effects and Adverse Reactions; Heart; Heart Diseases; Heart Failure; Humans; Iron Chelating Agents; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Randomized Controlled Trials as Topic; Razoxane; Risk Factors; Treatment Outcome

2010

Trials

1 trial(s) available for razoxane and Leukemia, Myeloid, Acute

ArticleYear
Efficacy of dexrazoxane as a cardioprotective agent in patients receiving mitoxantrone- and daunorubicin-based chemotherapy.
    Seminars in oncology, 1998, Volume: 25, Issue:4 Suppl 10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Agents; Daunorubicin; Female; Heart Diseases; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Razoxane

1998

Other Studies

18 other study(ies) available for razoxane and Leukemia, Myeloid, Acute

ArticleYear
The effect of dexrazoxane for clinical and subclinical cardiotoxicity in children with acute myeloid leukemia.
    Journal of pediatric hematology/oncology, 2010, Volume: 32, Issue:4

    Topics: Adolescent; Anthracyclines; Cardiovascular Agents; Child; Child, Preschool; Female; Follow-Up Studies; Heart Diseases; Humans; Infant; Leukemia, Myeloid, Acute; Male; Prospective Studies; Razoxane; Survival Rate; Treatment Outcome

2010
The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium.
    European journal of cancer (Oxford, England : 1990), 2011, Volume: 47, Issue:9

    Topics: Adolescent; Antineoplastic Agents; Cardiotonic Agents; Child; Child, Preschool; Female; Humans; Incidence; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Razoxane; Risk; Time Factors

2011
Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: analysis of a national cohort of patients in the Pediatric Health Information Systems database.
    Pediatric blood & cancer, 2013, Volume: 60, Issue:4

    Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cohort Studies; Databases, Factual; Female; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Razoxane; Retrospective Studies; Young Adult

2013
Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without compelling evidence.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Jul-20, Volume: 25, Issue:21

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hodgkin Disease; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Neoplasms, Second Primary; Randomized Controlled Trials as Topic; Razoxane; Risk Assessment; Scientific Misconduct; Sensitivity and Specificity; Survival Rate

2007
Acute myelomonocytic leukaemia after razoxane therapy.
    Lancet (London, England), 1981, Dec-12, Volume: 2, Issue:8259

    Topics: Female; Gastrointestinal Neoplasms; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Piperazines; Razoxane

1981
Leukaemia associated with razoxane.
    Lancet (London, England), 1982, Jan-02, Volume: 1, Issue:8262

    Topics: Humans; Leukemia, Myeloid, Acute; Piperazines; Razoxane

1982
Methotrexate in lieu of razoxane for incapacitating psoriasis.
    Lancet (London, England), 1984, Feb-25, Volume: 1, Issue:8374

    Topics: Humans; Leukemia, Myeloid, Acute; Methotrexate; Piperazines; Psoriasis; Razoxane; Skin Neoplasms

1984
Razoxane and leukaemia.
    Lancet (London, England), 1984, Aug-04, Volume: 2, Issue:8397

    Topics: Female; Humans; Leukemia, Myeloid, Acute; Middle Aged; Piperazines; Razoxane

1984
Leukaemia in psoriatic patients treated with razoxane.
    The British journal of dermatology, 1984, Volume: 110, Issue:5

    Topics: Humans; Leukemia, Myeloid, Acute; Piperazines; Psoriasis; Razoxane

1984
[140 cases of acute leukemia caused by bimolane].
    Zhonghua nei ke za zhi, 1993, Volume: 32, Issue:10

    Topics: Adult; Aged; Female; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Psoriasis; Razoxane; Retrospective Studies

1993
Coincident acute myelogenous leukemia and ischemic heart disease: use of the cardioprotectant dexrazoxane during induction chemotherapy.
    American journal of hematology, 1998, Volume: 59, Issue:3

    Topics: Adult; Aged; Cardiovascular Agents; Humans; Leukemia, Myeloid, Acute; Male; Myocardial Ischemia; Razoxane

1998
Razoxane in treatment of acute myeloid leukaemia.
    British medical journal, 1978, Sep-16, Volume: 2, Issue:6140

    Topics: Adolescent; Adult; Aged; Humans; Leukemia, Myeloid, Acute; Middle Aged; Piperazines; Razoxane; Remission, Spontaneous

1978
Razoxane in treatment of acute myeloid leukaemia.
    British medical journal, 1978, Oct-14, Volume: 2, Issue:6144

    Topics: Adolescent; Adult; Aged; Cytarabine; Drug Therapy, Combination; Humans; Leukemia, Myeloid, Acute; Middle Aged; Piperazines; Razoxane; Remission, Spontaneous

1978
Razoxane in treatment of acute myeloid leukaemia.
    British medical journal, 1978, Oct-21, Volume: 2, Issue:6145

    Topics: Cytarabine; Drug Therapy, Combination; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Piperazines; Razoxane

1978
Specific chromosomal translocations and therapy-related leukemia induced by bimolane therapy for psoriasis.
    Leukemia research, 1992, Volume: 16, Issue:11

    Topics: Adolescent; Adult; Humans; Karyotyping; Leukemia, Myeloid, Acute; Male; Middle Aged; Psoriasis; Razoxane; Translocation, Genetic; Treatment Outcome

1992
Razoxane and acute promyelocytic leukaemia.
    Lancet (London, England), 1987, Nov-07, Volume: 2, Issue:8567

    Topics: Aged; Female; Humans; Leukemia, Myeloid, Acute; Piperazines; Razoxane

1987
Acute myeloid leukaemia after treatment with razoxane.
    The British journal of dermatology, 1985, Volume: 113, Issue:2

    Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Piperazines; Prospective Studies; Psoriasis; Razoxane

1985
Risk of leukemia associated with chemotherapy.
    British medical journal (Clinical research ed.), 1985, Feb-16, Volume: 290, Issue:6467

    Topics: Humans; Leukemia, Myeloid, Acute; Male; Piperazines; Psoriasis; Razoxane; Risk

1985